MONDAY, AUGUST 21, 2017

Study shows promising outcomes from HIV maintenance therapy regimen

ViiV Healthcare, a specialist in HIV treatments, recently released the positive results of its Phase IIb study LATTE1 for investigational, injectable formulations of HIV maintenance therapies. Read More »

Discovery of single virus could enhance vaccines

Scientists say the discovery of a single virus that can generate a long-term immune response in specific areas of the body that are the first line of defense for fighting infections could be crucial to creating vaccines. Read More »

Janssen gains positive CHMP recommendation for EDURANT

Janssen-Cilag International NV recently received a positive opinion recommendation from the Committee for Medicinal Products for Human Use (CHMP), a branch of the European Medicines Agency (EMEA), for the company’s EDURANT to battle HIV. Read More »

Hemispherx receives positive opinion for MERS treatment

Hemispherx Biopharma Europe NV/SA, a branch of Hemispherx Biopharma Inc., recently announced that it has received a positive opinion for its new Middle East Respiratory Syndrome (MERS) from the Committee on Medical Products (COMP). Read More »

El Nino season connected to dengue fever epidemic

New research from an international team at the University of Pittsburgh Graduate School of Public Health shows that high temperatures in strong El Nino seasons are connected to dengue epidemics. Read More »

University of Pittsburgh receives grants for HIV cure

Husband-and-wife research team receives $6.3 million in NIH grants. Read More »

First patient receives Inovio's universal HIV vaccine

Clinical trial for PENNVAX-GP meant to determine tolerability and safety of vaccine. Read More »

Viral product provokes immune response against RSV

University of Pennsylvania researchers find human viral genomes may fight virus Read More »

Immunomic Therapeutics to present at Swiss Skin Vaccination Summit

Immunomic Therapeutics Inc., a privately held biotechnology company that creates vaccines using its proprietary LAMP technology, recently announced that a company representative will give a presentation at the Skin Vaccination Summit taking place in Lausanne, Switzerland, from Sept. 2 to 4. Read More »

Sen. Kitchen and DOH encourage parents to vaccinate kids before school starts

Sen. Shirley Kitchen recently backed up the encouragement of the Pennsylvania Department of Health (DOH), telling parents that they should have their children vaccinated before the school year begins. Read More »

Impax sells Daraprim rights to Turing Pharmaceuticals

According to a recent announcement, Turing Pharmaceuticals AG has purchased the United States rights of Impax Laboratories Inc.’s Daraprim brand for approximately $55 million. Read More »

Synflorix major label extension gains CHMP positive opinion

GlaxoSmithKline recently announced that it has received a positive opinion from the Committee for Medicine Products for Human Use (CHMP), which is a branch of the European Medicines Agency (EMA), concerning an expansion of a European label for Synflorix. Read More »

Pennsylvania reports year's 1st West Nile case

Venango County woman recently released from hospital with possible mosquito-borne virus Read More »

Skin immune cells remember and fight against parasites

University of Pennsylvania study finds T cells living in skin act just as other immune system cells do. Read More »

More than half of Americans unaware of hepatitis B vaccine

A national poll from REPASS Research and Strategic Consulting recently showed that more than 50 percent of Americans are not aware that there is a vaccine that is designed to protect them from the hepatitis B virus. Read More »

GlaxoSmithKline malaria candidate vaccine receives positive reviews

Mosquirix, the malaria candidate from GlaxoSmithKline, recently received positive feedback from regulators in Europe about the malaria prevention rates in young children who live in sub-Saharan Africa. Read More »

Adjuvants increase immune response for H7N9 flu vaccine

A team of scientists from The Wistar Institute recently found a specific set of mutations within influenza that has adapted to avoid the traditional vaccine design, making adjuvants more valuable in improving the immune response to vaccines like the H7N9 flu vaccine. Read More »

TetraLogic releases update about hepatitis B clinical program

TetraLogic Pharmaceuticals Corp., a clinical-stage biopharmaceutical company that is dedicated to discovering and creating innovative small molecule therapeutics in oncology as well as infectious diseases, recently released an update about its clinical program for hepatitis B (HBV). Read More »

HIV progression connected to cholesterol metabolism

Researchers from the University of Pittsburgh Graduate School of Public Health recently conducted a study showing a connection between cholesterol metabolism in immune cells and HIV progression. Read More »

bioCSL starts delivering AFLURIA vaccine for flu season

bioCSL Inc. recently announced that it has started to deliver the AFLURIA influenza vaccine for the 2015 and 2016 flu season in the U.S., showing the company’s support for improving the rates of seasonal flu vaccinations. Read More »